Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Science Blogs
ACI Profile for Alan Kotok
Featured in Alltop

Long-Acting Drug Blocks Opioid Effects, Withdrawal

Findings from a clinical trial show a formulation of the drug buprenorphine given once a week blocks effects of subsequent opioid exposure and withdrawal symptoms. . . . → Read More: Long-Acting Drug Blocks Opioid Effects, Withdrawal

FDA Approves Skin Infection Drug

The U.S. Food and Drug Administration approved a new drug that treats serious bacterial skin infections, including those often resistant to current antibiotics. . . . → Read More: FDA Approves Skin Infection Drug

FDA Developing Digital Device Certification Process

The U.S. Food and Drug Administration expects to unveil a new procedure for certifying digital medical devices that the agency says should speed their entry to the market. . . . → Read More: FDA Developing Digital Device Certification Process

Supreme Court Cuts Biosimilar Waiting Time

The U.S. Supreme Court ruled yesterday that makers of biologic drugs similar to branded originals need not wait an additional 6 months to begin marketing their products. . . . → Read More: Supreme Court Cuts Biosimilar Waiting Time

Symptom Alerts Linked to Longer Cancer Survival

A clinical trial shows cancer patients using an online system to report their symptoms have somewhat longer survival times than patients not using this service. . . . → Read More: Symptom Alerts Linked to Longer Cancer Survival

Acne Drug Shown to Treat Early Multiple Sclerosis

A clinical trial in Canada shows a common and inexpensive antibiotic to treat acne can reduce the chance early-stage multiple sclerosis becomes a full-blown disease. . . . → Read More: Acne Drug Shown to Treat Early Multiple Sclerosis

Precision Medicine Trial Shows Reduced Pain, Opioid Use

A large-scale clinical trial tracking pain treatments guided by genetic testing shows large majorities of participants report less pain, with fewer individuals using opioid drugs. . . . → Read More: Precision Medicine Trial Shows Reduced Pain, Opioid Use

Fixed-Dose Blood Pressure Drugs Shown Cost-Effective

An analysis of medical insurance claims shows fixed-dose combination drugs to be the most cost-effective medication strategy for people with hypertension, or high blood pressure. . . . → Read More: Fixed-Dose Blood Pressure Drugs Shown Cost-Effective

Bacteria Traffic Tracked in New Hospital

The opening of a new hospital in Chicago offered an opportunity to follow the formation of bacterial communities and their movement in a health care facility. . . . → Read More: Bacteria Traffic Tracked in New Hospital

Trial Begins of Freeze-Dried Blood Plasma

A clinical trial is underway testing the safety and practicality of using a person’s own freeze-dried blood plasma for transfusions, substituting for frozen or liquid plasma. . . . → Read More: Trial Begins of Freeze-Dried Blood Plasma